Panel 4: Recent advances in otitis media in molecular biology, biochemistry, genetics, and animal models

Otolaryngology - Head and Neck Surgery (United States)

Volumn 148, Issue 4 SUPPL., 2013, Pages

  Li, Jian Dong ^a   Hermansson, Ann ^b   Ryan, Allen F ^c   Bakaletz, Lauren O ^d   Brown, Steve D ^e   Cheeseman, Michael T ^e   Juhn, Steven K ^f   Jung, Timothy T K ^g   Lim, David J ^h   Lim, Jae Hyang ^a   Lin, Jizhen ^f   Moon, Sung Kyun ^h   Post, J C ⁱ  

^a GEORGIA STATE UNIVERSITY   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HOUSE EAR INSTITUTE   (United States)

ⁱ ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Biochemistry; Cell signaling; Chemokine; Cytokine; Inflammation; Innate immunity; Molecular biology; Otitis media; Tissue remodeling

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INHIBITOR OF DIFFERENTIATION 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN; MUCIN 1; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUCIN 7; MUCIN 8; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; PROTEIN P73; THYROID TRANSCRIPTION FACTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE;

ARTICLE; BRAIN STEM RESPONSE; CELL CYCLE PROGRESSION; COCHLEA AQUEDUCT; CONDUCTION DEAFNESS; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; INNATE IMMUNITY; INNER EAR; LACTOBACILLUS RHAMNOSUS; MACROPHAGE ACTIVATION; MIDDLE EAR; MIDDLE EAR EFFUSION; MIDDLE EAR MUCOSA; MOLECULAR BIOLOGY; MOLECULAR PATHOLOGY; NONHUMAN; OTITIS MEDIA; PERCEPTION DEAFNESS; PHENOTYPE; PROTEIN EXPRESSION; SCALA TYMPANI; STRIA VASCULARIS; UPREGULATION; ANIMAL; BLOOD; CHILD; DISEASE MODEL; EVIDENCE BASED MEDICINE; GENETICS; IMMUNOLOGY; MICROBIOLOGY; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; CHEMOKINES; CHILD; CYTOKINES; DISEASE MODELS, ANIMAL; EAR, INNER; EAR, MIDDLE; EVIDENCE-BASED MEDICINE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HEARING LOSS, CONDUCTIVE; HUMANS; IMMUNITY, INNATE; OTITIS MEDIA;

MLCS; MLOWN;

EID: 84878853993     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813479772     Document Type: Article

References (75)

1. Wiertsema SP, Leach AJ. Theories of otitis media pathogenesis, with a focus on indigenous children. Med J Aust. 2009; 191:S50-S54.
2. Prommalikit O, Pengsaa K, Thisyakorn U. Pneumococcal infections in high-risk and immunocompromised hosts. J Med Assoc Thai. 2010;93(suppl 5):S61-S70.
3. Ilia S, Goulielmos GN, Samonis G, et al. Host's response in otitis media: understanding genetic susceptibility. Pediatr Infect Dis J. 2008;27:929-933.
4. Kim MG, Park DC, Shim JS, et al. TLR-9, NOD-1, NOD-2, RIG-I and immunoglobulins in recurrent otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2010;74:1425-1429.
5. Lee HY, Takeshita T, Shimada J, et al. Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38MAPK signaling pathway in human middle ear epithelial cells. BMC Infect Dis. 2008;8:87.
6. Lee YC, Kim C, Shim JS, et al. Toll-like receptors 2 and 4 and their mutations in patients with otitis media and middle ear effusion. Clin Exp Otorhinolaryngol. 2008;1:189-195.
7. Song JJ, Cho JG, Woo JS, et al. Differential expression of Toll-like receptors 2 and 4 in rat middle ear. Int J Pediatr Otorhinolaryngol. 2009;73:821-824.
8. Hirano T, Kodama S, Fujita K, et al. Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media. FEMS Immunol Med Microbiol. 2007;49:75-83.
9. Leichtle A, Hernandez M, Pak K, et al. TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media. Innate Immun. 2009;15:205-215.
10. MacArthur CJ, Pillers DA, Pang J, et al. Gram-negative pathogen Klebsiella oxytoca is associated with spontaneous chronic otitis media in Toll-like receptor 4-deficient C3H/HeJ mice. Acta Otolaryngol. 2008;128:132-138.
11. Leichtle A, Hernandez M, Pak K, et al. The Toll-like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery. BMC Immunol. 2009;10:45.
12. Hernandez M, Leichtle A, Pak K, et al. Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. J Infect Dis. 2008;198:1862-1869.
13. Leichtle A, Hernandez M, Ebmeyer J, et al. CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF-/-mice. J Immunol. 2010;184:3087-3097.
14. Bogaert D, Thompson CM, Trzcinski K, et al. The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model. Vaccine. 2010;28: 681-685.
15. Tong HH, Li YX, Stahl GL, et al. Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2. Infect Immun. 2010;78:976-983.
16. McGillivary G, Mason KM, Jurcisek JA, et al. Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae. Cell Microbiol. 2009;11:1399-1408.
17. Bakaletz LO. Immunopathogenesis of polymicrobial otitis media. J Leukoc Biol. 2010;87:213-222.
18. Lim JH, Ha U, Sakai A, et al. Streptococcus pneumoniae synergizes with nontypeable Haemophilus influenzae to induce inflammation via upregulating TLR2. BMC Immunol. 2008;9:40.
19. Krishnamurthy A, McGrath J, Cripps AW, et al. The incidence of Streptococcus pneumoniae otitis media is affected by the polymicrobial environment particularly Moraxella catarrhalis in a mouse nasal colonisation model. Microbes Infect. 2009; 11:545-553.
20. Weimer KE, Armbruster CE, Juneau RA, et al. Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease. J Infect Dis. 2010;202: 1068-1075.
21. Skovbjerg S, Roos K, Holm SE, et al. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child. 2009;94:92-98.
22. Lee DH, Yeo SW, Chang KH, et al. Effect of infliximab on experimentally induced otitis media in rats. Ann Otol Rhinol Laryngol. 2008;117:470-476.
23. Ebmeyer J, Leichtle A, Hernandez M, et al. TNFA deletion alters apoptosis as well as caspase 3 and 4 expression during otitis media. BMC Immunol. 2011;12:12.
24. Brown SD, Hardisty-Hughes RE, Mburu P. Quiet as a mouse: dissecting the molecular and genetic basis of hearing. Nat Rev Genet. 2008;9:277-290.
25. Shimada J, Moon SK, Lee HY, et al. Lysozyme M deficiency leads to an increased susceptibility to Streptococcus pneumoniae-induced otitis media. BMC Infect Dis. 2008;8:134.
26. Leichtle A, Lai Y, Wollenberg B, et al. Innate signaling in otitis media: pathogenesis and recovery. Curr Allergy Asthma Rep. 2011;11:78-84.
27. Han F, Yu H, Tian C, et al. Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis media. Infect Immun. 2009;77:3100-3108.
28. Leichtle A, Hernandez M, Lee J, et al. The role of DNA sensing and innate immune receptor TLR9 in otitis media. Innate Immun. 2012;18:3-13.
29. Byun JY, Yune TY, Lee JY, et al. Expression of CYLD and NF-kappaB in human cholesteatoma epithelium. Mediators Inflamm. 2010;2010:796315.
30. Lim JH, Jono H, Koga T, et al. Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice. PLoS One. 2007;2:e1032.
31. Depreux FF, Darrow K, Conner DA, et al. Eya4-deficient mice are a model for heritable otitis media. J Clin Invest. 2008;118: 651-658.
32. Rye MS, Wiertsema SP, Scaman ES, et al. FBXO11, a regulator of the TGFbeta pathway, is associated with severe otitis media in Western Australian children. Genes Immun. 2011;12:352-359.
33. Noben-Trauth K, Latoche JR. Ectopic mineralization in the middle ear and chronic otitis media with effusion caused by RPL38 deficiency in the Tail-short (Ts) mouse. J Biol Chem. 2011;286:3079-3093.
34. Song JJ, Kwon SK, Cho CG, et al. Microarray analysis of microRNA expression in LPS induced inflammation of human middle ear epithelial cells (HMEECs) [published online March 4, 2011]. Int J Pediatr Otorhinolaryngol.
35. Kerschner JE, Khampang P, Samuels T. Extending the chinchilla middle ear epithelial model for mucin gene investigation. Int J Pediatr Otorhinolaryngol. 2010;74:980-985.
36. Tsuchiya K, Komori M, Zheng QY, et al. Interleukin-10 is an essential modulator of mucoid metaplasia in a mouse otitis media model. Ann Otol Rhinol Laryngol. 2008;117:630-636.
37. Curran DR, Cohn L. Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease. Am J Respir Cell Mol Biol. 2010;42:268-275.
38. Lee YW, Chung Y, Juhn SK, et al. Activation of the transforming growth factor beta pathway in bacterial otitis media. Ann Otol Rhinol Laryngol. 2011;120:204-213.
39. Furukawa M, Ebmeyer J, Pak K, et al. Jun N-terminal protein kinase enhances middle ear mucosal proliferation during bacterial otitis media. Infect Immun. 2007;75:2562-2571.
40. Yaguchi Y, Wada K, Uchimizu H, et al. Middle ear mucosa regeneration by grafting of artificial mucosa. Acta Otolaryngol. 2007;127:1038-1044.
41. Zhang QA, Hamajima Y, Zhang Q, et al. Identification of Id1 in acquired middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg. 2008;134:306-310.
42. Hamajima Y, Komori M, Preciado DA, et al. The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media. Cell Prolif. 2010;43:457-463.
43. Kerschner JE. Mucin gene expression in human middle ear epithelium. Laryngoscope. 2007;117:1666-1676.
44. Kerschner JE, Lin J, Tsushiya K, et al. Mucin gene expression and mouse middle ear epithelium. Int J Pediatr Otorhinolaryngol. 2010;74:864-868.
45. Kerschner JE, Tripathi S, Khampang P, et al. MUC5AC expression in human middle ear epithelium of patients with otitis media. Arch Otolaryngol Head Neck Surg. 2010;136:819-824.
46. Ubell ML, Kerschner JE, Wackym PA, et al. MUC2 expression in human middle ear epithelium of patients with otitis media. Arch Otolaryngol Head Neck Surg. 2008;134:39-44.
47. Ubell ML, Khampang P, Kerschner JE. Mucin gene polymorphisms in otitis media patients. Laryngoscope. 2010;120: 132-138.
48. Kerschner JE, Khampang P, Erbe CB, et al. Mucin gene 19 (MUC19) expression and response to inflammatory cytokines in middle ear epithelium. Glycoconj J. 2009;26:1275-1284.
49. Lin J, Tsuprun V, Kawano H, et al. Characterization of mucins in human middle ear and eustachian tube. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1157-L1167.
50. Takeuchi K, Yagawa M, Ishinaga H, et al. Mucin gene expression in the effusions of otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2003;67:53-58.
51. Ha UH, Lim JH, Kim HJ, et al. MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway. J Biol Chem. 2008;283:30624-30631.
52. Shen H, Yoshida H, Yan F, et al. Synergistic induction of MUC5AC mucin by nontypeable Haemophilus influenzae and Streptococcus pneumoniae. Biochem Biophys Res Commun. 2008;365:795-800.
53. Huang Y, Mikami F, Jono H, et al. Opposing roles of PAK2 and PAK4 in synergistic induction of MUC5AC mucin by bacterium NTHi and EGF. Biochem Biophys Res Commun. 2007; 359:691-696.
54. Lim JH, Kim HJ, Komatsu K, et al. Differential regulation of Streptococcus pneumoniae-induced human MUC5AC mucin expression through distinct MAPK pathways. Am J Transl Res. 2009;1:300-311.
55. Kim SJ, Choi JY, Son EJ, et al. Interleukin-1beta upregulates Na1-K1-2Cl-cotransporter in human middle ear epithelia. J Cell Biochem. 2007;101:576-586.
56. Cho JG, Woo JS, Lee HM, et al. Effects of cigarette smoking on mucin production in human middle ear epithelial cells. Int J Pediatr Otorhinolaryngol. 2009;73:1447-1451.
57. Preciado D, Lin J, Wuertz B, et al. Cigarette smoke activates NF kappa B and induces Muc5b expression in mouse middle ear cells. Laryngoscope. 2008;118:464-471.
58. Kong SK, Chon KM, Goh EK, et al. Histologic changes in the auditory tube mucosa of rats after long-term exposure to cigarette smoke. Am J Otolaryngol. 2009;30:376-382.
59. Block BB, Kuo E, Zalzal HG, et al. In vitro effects of acid and pepsin on mouse middle ear epithelial cell viability and MUC5B gene expression. Arch Otolaryngol Head Neck Surg. 2010;136:37-42.
60. Ichimiya I, Kurono Y, Hirano T, et al. Changes in immunostaining of inner ears after antigen challenge into the scala tympani. Laryngoscope. 1998;108:585-591.
61. Joglekar S, Morita N, Cureoglu S, et al. Cochlear pathology in human temporal bones with otitis media. Acta Otolaryngol. 2010;130:472-476.
62. Margolis RH, Hunter LL, Rykken JR, et al. Effects of otitis media on extended high-frequency hearing in children. Ann Otol Rhinol Laryngol. 1993;102:1-5.
63. Morizono T, Tono T. Middle ear inflammatory mediators and cochlear function. Otolaryngol Clin North Am. 1991;24:835-843.
64. MacArthur CJ, Pillers DA, Pang J, et al. Altered expression of middle and inner ear cytokines in mouse otitis media. Laryngoscope. 2011;121:365-371.
65. Nonaka M, Ogihara N, Fukumoto A, et al. Poly(I:C) synergizes with Th2 cytokines to induce TARC/CCL17 in middle ear fibroblasts established from mucosa of otitis media with effusion. Acta Otolaryngol Suppl. 2009;(562): 57-62.
66. Preciado D, Goyal S, Rahimi M, et al. MUC5B is the predominant mucin glycoprotein in chronic otitis media fluid. Pediatr Res. 2010;68:231-236.
67. Lim DJ, Chun YM, Lee HY, et al. Cell biology of tubotympanum in relation to pathogenesis of otitis media-A review. Vaccine. 2000;19(suppl 1):S17-S25.
68. Minami S, Kobayashi H, Yamashita A, et al. Selective expression of aquaporin 1, 4 and 5 in the rat middle ear. Hear Res. 2001;158:51-56.
69. Zhang Q, Liu C, Wang J, et al. Expression pattern of aquaporin 4 and 5 in the middle ear of guinea pigs with secretory otitis media. Acta Otolaryngol. 2010;130:68-74.
70. Schachern PA, Tsuprun V, Cureoglu S, et al. Effect of apolactoferrin on experimental pneumococcal otitis media. Arch Otolaryngol Head Neck Surg. 2010;136:1127-1131.
71. Paparella MM. Sudden deafness secondary to a middle ear/inner ear interaction: the implications of finding an ''adhesive tent'' during tympanotomy. Ear Nose Throat J. 2009;88:776-777.
72. Yoshida H, Miyamoto I, Takahashi H. Is sensorineural hearing loss with chronic otitis media due to infection or aging in older patients? Auris Nasus Larynx. 2009;36:269-273.
73. MacArthur CJ, Kempton JB, DeGagne J, et al. Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids. Otolaryngol Head Neck Surg. 2008;139:646-653.
74. Ghaheri BA, Kempton JB, Pillers DA, et al. Cochlear cytokine gene expression in murine acute otitis media. Laryngoscope. 2007;117:22-29.
75. Xu X, Woo CH, Steere RR, et al. EVI1 acts as an inducible negative-feedback regulator of NF-kappaB by inhibiting p65 acetylation. J Immunol. 2012;188:6371-6380.